In 2017, the global Specimen Validity Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
This report focuses on the global Specimen Validity Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Specimen Validity Testing development in United States, Europe and China.
The key players covered in this study
Thermo Fisher (US)
American Bio Medica Corporation (ABMC)
Express Diagnostics (US)
Premier Biotech (US)
Quest Diagnostics (US)
Alere Toxicology (US)
ACM Global Laboratories (US)
Clinical Reference Laboratory (CRL) (US)
Market segment by Type, the product can be split into
Market segment by Application, split into
Drug Screening Laboratories
Criminal Justice and Law Enforcement Agencies
Pain Management Centers
Drug Rehabilitation Centers
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Specimen Validity Testing status, future forecast, growth opportunity, key market and key players.
To present the Specimen Validity Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Specimen Validity Testing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.